Macular Degeneration Association (MDA) Announces Its 2011 Spring Educational Conference
The Macular Degeneration Association will be presenting a one-day educational conference to provide age-related macular degeneration (AMD) patients and their caregivers in Southwest Florida with an opportunity to learn about the latest drugs, treatments, and therapies for macular degeneration that can enhance their lives.
- Tampa-St. Petersburg-Clearwater, FL (1888PressRelease) February 25, 2011 - ADVANCES IN THE TREATMENT OF WET AND DRY MACULAR DEGENERATION,
WHAT PATIENTS SHOULD KNOW!
FIRST ANNUAL MDA MACULAR DEGENERATION CONFERENCE
Tampa Westshore Marriott Tampa, Florida
Saturday, March 26, 2011
8:30 A.M. - 5:00 P.M.
Program chair: Dr. Michael Tolentino
The Macular Degeneration Association will be presenting a one-day educational conference to provide age-related macular degeneration (AMD) patients and their caregivers in Southwest Florida with an opportunity to learn about the latest drugs, treatments, and therapies for macular degeneration that can enhance their lives. The conference is also a forum for patients and caregivers to share their concerns and successes with macular experts and other local patients.
The Conference will have general session presentations beginning in the morning that will continue throughout the day, exhibition sessions during the sponsored breaks, and a question and answer session at the conclusion of the conference. Presentations will be given by prominent macular degeneration physicians and clinicians to include: Dr. Michael Tolentino, Dr. Sonya Braudway, Dr. Dana Deupree, Dr. Karen Gehrs, Dr. Benjamin Kim, Dr. Brian Madow, etc. Patients and their caregivers will also be given the opportunity to participate in the panel discussion and a meet and greet with the doctors.
Program Topics include:
• Opening Remarks: Chairman, Lawrence Hoffheimer
• What is Macular Degeneration
• What is Examined in the Doctors Office
• Current treatments for Dry Macular Degeneration
• Future Treatments for Dry Macular Degeneration
• Clinical Trials offered for treating Dry Macular Degeneration
• Current Treatment for Wet Macular Degeneration
• Future Treatments for Wet Macular Degeneration
• New Telescope Implant
• Low Vision
• Alternative Therapies
• Questions Patients are Embarrassed to Ask Their Doctor (panel)
About the Macular Degeneration Association (MDA)
The Macular Degeneration Association is a nonprofit health organization providing age-related macular degeneration research, information and advocacy. The mission of the organization is to cure macular degeneration and to improve the lives of all people affected by the disease. To fulfill this mission, the Macular Degeneration Association funds research, publishes scientific findings, provides funding for information and other services to people with macular degeneration, their families, health care professionals and to the general public.
The money raised by the foundation funds research, information programs, advocacy and awareness efforts that will support the over 9.1 million people with macular degeneration in communities across America.